Attitudes Toward Postmenopausal Long-Term Hormone Therapy.

Kolip P, Höfling-Engels N, Schmacke N (2009)
Qualitative Health Research 19(2): 207-215.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Kolip, PetraUniBi ; Höfling-Engels, Nicole; Schmacke, Norbert
Einrichtung
Fakultät für Gesundheitswissenschaften > AG 4 Prävention und Gesundheitsförderung
Erscheinungsjahr
2009
Zeitschriftentitel
Qualitative Health Research
Band
19
Ausgabe
2
Seite(n)
207-215
ISSN
1049-7323
Page URI
https://pub.uni-bielefeld.de/record/1939726

Zitieren

Kolip P, Höfling-Engels N, Schmacke N. Attitudes Toward Postmenopausal Long-Term Hormone Therapy. Qualitative Health Research. 2009;19(2):207-215.
Kolip, P., Höfling-Engels, N., & Schmacke, N. (2009). Attitudes Toward Postmenopausal Long-Term Hormone Therapy. Qualitative Health Research, 19(2), 207-215. https://doi.org/10.1177/1049732308328053
Kolip, Petra, Höfling-Engels, Nicole, and Schmacke, Norbert. 2009. “Attitudes Toward Postmenopausal Long-Term Hormone Therapy.”. Qualitative Health Research 19 (2): 207-215.
Kolip, P., Höfling-Engels, N., and Schmacke, N. (2009). Attitudes Toward Postmenopausal Long-Term Hormone Therapy. Qualitative Health Research 19, 207-215.
Kolip, P., Höfling-Engels, N., & Schmacke, N., 2009. Attitudes Toward Postmenopausal Long-Term Hormone Therapy. Qualitative Health Research, 19(2), p 207-215.
P. Kolip, N. Höfling-Engels, and N. Schmacke, “Attitudes Toward Postmenopausal Long-Term Hormone Therapy.”, Qualitative Health Research, vol. 19, 2009, pp. 207-215.
Kolip, P., Höfling-Engels, N., Schmacke, N.: Attitudes Toward Postmenopausal Long-Term Hormone Therapy. Qualitative Health Research. 19, 207-215 (2009).
Kolip, Petra, Höfling-Engels, Nicole, and Schmacke, Norbert. “Attitudes Toward Postmenopausal Long-Term Hormone Therapy.”. Qualitative Health Research 19.2 (2009): 207-215.

5 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Situating and Constructing Diversity in Semi-Structured Interviews.
McIntosh MJ, Morse JM., Glob Qual Nurs Res 2(), 2015
PMID: 28462313
Lifestyle risk management--a qualitative analysis of women's descriptions of taking hormone therapy following surgically induced menopause.
Crowe M, Burrell B, Whitehead L., J Adv Nurs 68(8), 2012
PMID: 22082259
Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis.
Tao M, Teng Y, Shao H, Wu P, Mills EJ., PLoS One 6(9), 2011
PMID: 21949743
Menopause narratives: the interplay of women's embodied experiences with biomedical discourses.
Hyde A, Nee J, Howlett E, Drennan J, Butler M., Qual Health Res 20(6), 2010
PMID: 20181821
Women's decision making during the menopausal transition.
Theroux R., J Am Acad Nurse Pract 22(11), 2010
PMID: 21054635

22 References

Daten bereitgestellt von Europe PubMed Central.


AUTHOR UNKNOWN, 0
Reporting on post-menopausal hormone therapy: an analysis of gynaecologists' web pages.
Bucksch J, Kolip P, Deitermann B., Med Inform Internet Med 29(3-4), 2004
PMID: 15742988

Coney,, 1994
Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.
Du Y, Doren M, Melchert HU, Scheidt-Nave C, Knopf H., BMC Womens Health 7(), 2007
PMID: 17945013

European, 2003

Food, 2008
Hormone therapy after the Women's Health Initiative: a qualitative study.
French LM, Smith MA, Holtrop JS, Holmes-Rovner M., BMC Fam Pract 7(), 2006
PMID: 17059606

Glaser,, 1967
Health professionals, their medical interventions and uncertainty: a study focusing on women at midlife.
Griffiths F, Green E, Bendelow G., Soc Sci Med 62(5), 2005
PMID: 16233942
Risk communication in consultations about hormone therapy in the menopause: concordance in risk assessment and framing due to the context.
Hoffmann M, Hammar M, Kjellgren KI, Lindh-Astrand L, Ahlner J., Climacteric 9(5), 2006
PMID: 17000583
Hormone replacement therapy in the menopause. Structure and content of risk talk.
Hoffmann M, Lindh-Astrand L, Ahlner J, Hammar M, Kjellgren KI., Maturitas 50(1), 2005
PMID: 15590209

AUTHOR UNKNOWN, 0
Hormone replacement therapy: determinants of women's decisions.
Marmoreo J, Brown JB, Batty HR, Cummings S, Powell M., Patient Educ Couns 33(3), 1998
PMID: 9731166
Feminist ethics and menopause: autonomy and decision-making in primary medical care.
Murtagh MJ, Hepworth J., Soc Sci Med 56(8), 2003
PMID: 12639581

National, 2008
Prevalence and causes of persistent use of hormone replacement therapy among postmenopausal women: a follow-up study.
Ness J, Aronow WS., Am J Ther 13(2), 2006
PMID: 16645425
Loyalties in clinical research on drugs: the case of hormone replacement therapy.
Palmlund I., Soc Sci Med 63(2), 2006
PMID: 16490295

Schütze,, Neue Praxis 13(), 1983

Schwabe,, 2006
Women's Experience at the Time of Menopause: Accounting for Biological, Cultural and Psychological Embodiment.
Stephens C., J Health Psychol 6(6), 2001
PMID: 22049468
Menopause and the virtuous woman: the importance of the moral order in accounting for medical decision making.
Stephens C, Breheny M., Health (London) 12(1), 2008
PMID: 18073244
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators., JAMA 288(3), 2002
PMID: 12117397
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 19050178
PubMed | Europe PMC

Suchen in

Google Scholar